Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia

Katharina Elisabeth Fischer, Thomas Heisser and Tom Stargardt ()
Authors registered in the RePEc Author Service: Katharina Elisabeth Blankart

Health Policy, 2016, vol. 120, issue 10, 1115-1122

Abstract: Little is known on the performance of the newly introduced health benefit assessment process, AMNOG, in Germany compared to other health technology assessment agencies.

Keywords: Decision making; Priority setting; Early Benefit Assessment; Reimbursement of pharmaceuticals (search for similar items in EconPapers)
Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (8)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851016302044
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:120:y:2016:i:10:p:1115-1122

DOI: 10.1016/j.healthpol.2016.08.001

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().